Funding Received
$58 Million in 2 Rounds from 8 Investors
Most Recent Funding
$12 Million Series D on May 27, 2009
Headquarters:
Cambridge, MA
Description:
Elixir Pharmaceuticals develops and commercializes pharmaceuticals for the treatment of metabolic diseases.
Founders:
Lenny Guarente
Categories:
Diabetes, Pharmaceuticals, Biotechnology
Website:
http://elixirpharm.com

Company Details

Update

Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Company’s scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.

Current Team (1)

Update

Past Team (5)

Update

Board Members and Advisors (2)

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • Headquarters

    300 Putnam Avenue

    Cambridge, MA 02139

    USA

Images (1)

Update
  • 3fe5eef0624314dd5a3d45788f0830eb